AbbVie Inc.
$514.13B- Market cap
- $454.36B
- Debt
- +$65.00B
- Cash
- −$5.23B
Capital structure 87% equity / 13% debt · EV / Revenue 8.41x · EV proxy / EBITDA proxy 22.15x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $454.36B · View financials
Snapshot Sep 11, 2026, 4:00 PM ET
FY 2026 · Mkt cap
Decision snapshot: ABBV stock price vs COTY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at COTY's multiple
Needs COTY P/E.
Implied fair value · at ABBV's multiple
Needs Annual EPS is negative.
Snapshot Sep 11, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Multiple premium
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 87% equity / 13% debt · EV / Revenue 8.41x · EV proxy / EBITDA proxy 22.15x
Capital structure 44% equity / 56% debt · EV / Revenue 0.90x · EV proxy / EBITDA proxy 13.10x
ABBV carries the larger enterprise value at $514.13B against $5.25B; COTY trades on the lower EV / Revenue multiple (0.90x vs 8.41x); COTY on the lower EV / EBITDA (13.10x vs 22.15x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AbbVie Inc. · implied price per share
Bear
$87.89
Base
$110.94
Bull
$142.98
COTY INC. · implied price per share
Bear
$1.26
Base
$2.06
Bull
$3.11
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Pfizer Inc.
ABBV vs PFE
Johnson & Johnson
ABBV vs JNJ
Merck & Co., Inc.
ABBV vs MRK
Eli Lilly and Company
ABBV vs LLY
Amgen Inc.
ABBV vs AMGN
Gilead Sciences, Inc.
ABBV vs GILD
ESTEE LAUDER COMPANIES INC
ABBV vs EL
e.l.f. Beauty, Inc.
ABBV vs ELF
EDGEWELL PERSONAL CARE Co
ABBV vs EPC
Ulta Beauty, Inc.
ABBV vs ULTA
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.